US Health Secretary Robert F. Kennedy Jr. has faced backlash for terminating $500 million in mRNA vaccine contracts based on ...

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

US Health Secretary Robert F. Kennedy Jr. cited false claims to justify terminating 22 federal contracts for mRNA-based ...

Stocks in the health-care industry rose as markets grew more confident that U.S. borrowing costs will fall, while companies in the sector pleased investors in their quarterly reports. Gilead Sciences ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

HHS Secretary Kennedy’s decision is based on a fundamental misunderstanding of vaccinology that could cost lives in future pandemics.

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will boost global vulnerability to future pandemics.

GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...